LifeStance Health Group, Inc. LFST

Set alert

Price alert · LFST

All alert types
13.26 USD -0.14 -1.04%

At close · Nov 2

13.50 +0.24 +1.81%

After hours · Nov 2, 4:00 PM ET

Bid
13.26 × 2
Ask
13.27 × 2
13.18 Day range 13.60
4.77 52-week range 13.76
YTD
+88.35%
1 year
+170.61%
Open
13.50
Prev close
13.40
Mkt cap
5.04B
Vol
3.36M
Avg vol
4.40M
EPS
0.13
P/E
102.00
Div yield
0.00%
More statistics
Low
13.18
High
13.60
Forward P/E
30.78
Beta
1.30
Short ratio
2.99
Inst. own
89.69%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
12.48
200-d avg
9.34
1y target
14.45

3M chart

Chart tools
Interval

Events in this range
  • Aug 6, 2026Earnings: 0.06; estimate 0.03275; surprise 83.21%
  • Aug 7, 2026Rating: BTIG · Buy → Buy
  • Aug 14, 2026Rating: JP Morgan · Neutral → Neutral
  • Aug 19, 2026Rating: BTIG · Buy → Buy
  • Sep 9, 2026Rating: Canaccord Genuity · Buy → Buy
  • Sep 10, 2026Rating: Barclays · Overweight → Overweight
  • Oct 5, 2026Rating: Keybanc · Overweight → Overweight
Signals (24)
NameDateAgo
RSI: OverboughtOct 29, 20264 days ago
SMA: BullishOct 22, 20261 week ago
MACD: Buy SignalOct 22, 20261 week ago
SMA: BullishOct 21, 20261 week ago
SMA: BearishOct 16, 20262 weeks ago
MACD: Sell SignalOct 16, 20262 weeks ago
SMA: BearishOct 15, 20262 weeks ago
SMA: BullishOct 14, 20262 weeks ago
SMA: BearishOct 13, 20262 weeks ago
SMA: BullishOct 12, 20263 weeks ago
MACD: Buy SignalOct 12, 20263 weeks ago
SMA: BullishOct 9, 20263 weeks ago
SMA: BearishOct 8, 20263 weeks ago
SMA: BullishOct 5, 20264 weeks ago
SMA: BearishOct 1, 20261 month ago
SMA: BullishSep 30, 20261 month ago
SMA: BearishSep 24, 20261 month ago
SMA: BearishSep 22, 20261 month ago
MACD: Sell SignalSep 15, 20261 month ago
MACD: Buy SignalSep 14, 20261 month ago

Newest 20 of 24.

Analyst view

Consensus: buy

Buy
Price target (mean) 14.45 +9.0% upside
Target (low)
12.00
Target (mean)
14.45
Target (high)
18.00
Ratings (0m) 11 9 buy · 2 hold · 0 sell
  • Strong buy2
  • Buy7
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 11
  • 1 month ago 11
  • 2 months ago 11

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

LFST analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.083880.07 – 0.0950.01444+480.9%431.58M+18.6%5
Next quarter0.086590.07 – 0.0980.08856-2.2%438.56M+14.8%5
Current year0.359510.32 – 0.3880.1824+97.1%1.71B+20.0%5
Next year0.430750.38 – 0.5080.35951+19.8%1.96B+14.5%5

Upgrades and downgrades

The latest rating changes

LFST analyst upgrades and downgrades
DateFirmActionFromTo
Oct 5, 2026KeybancMaintainedOverweightOverweight
Sep 10, 2026BarclaysMaintainedOverweightOverweight
Sep 9, 2026Canaccord GenuityMaintainedBuyBuy
Aug 19, 2026BTIGMaintainedBuyBuy
Aug 14, 2026JP MorganMaintainedNeutralNeutral
Aug 7, 2026BTIGMaintainedBuyBuy
Jul 24, 2026BTIGMaintainedBuyBuy
Jul 21, 2026Canaccord GenuityMaintainedBuyBuy
Jul 14, 2026BarclaysMaintainedOverweightOverweight
Jul 13, 2026KeybancMaintainedOverweightOverweight
Jun 5, 2026Goldman SachsInitiatedBuyNeutral
May 14, 2026JP MorganMaintainedNeutralNeutral
May 8, 2026BTIGMaintainedBuyBuy
Mar 6, 2026BarclaysMaintainedOverweightOverweight
Feb 26, 2026Canaccord GenuityMaintainedBuyBuy
Feb 26, 2026UBSMaintainedBuyBuy
Feb 26, 2026KeybancMaintainedOverweightOverweight
Feb 2, 2026BTIGMaintainedBuyBuy
Dec 12, 2025BTIGMaintainedBuyBuy
Dec 9, 2025BarclaysInitiated—Overweight
Nov 13, 2025BMO CapitalInitiated—Outperform
Nov 7, 2025UBSMaintainedBuyBuy
Nov 6, 2025BTIGMaintainedBuyBuy
Aug 8, 2025UBSMaintainedBuyBuy
May 27, 2025UBSUpgradeNeutralBuy
Apr 8, 2025KeybancInitiated—Overweight
Apr 3, 2025Canaccord GenuityInitiated—Buy
Dec 16, 2024Goldman SachsUpgradeNeutralBuy
Nov 11, 2024BarclaysMaintainedUnderweightUnderweight
Aug 15, 2024UBSMaintainedNeutralNeutral